Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation

Table 4

Medication after kidney transplantation.

Time after transplantation	0	1 month	12 months	24 months	36 months
Available data	27	27	19	15	11
Calcium carbonate	19 (70%)	13 (48%)	4 (21%)	2 (13%)	0 (0%)
Vitamin D analogues	21 (78%)	18 (67%)	7 (37%)	6 (40%)	4 (36%)
Cholecalciferol	1 (4%)	0 (0%)	1 (5%)	0 (0%)	1 (9%)
Alfacalcidol	13 (48%)	11 (41%)	3 (16%)	4 (27%)	2 (18%)
Calcitriol	8 (30%)	7 (26%)	3 (16%)	2 (13%)	2 (18%)
Bisphosphonate		16 (59%)	12 (63%)	10 (67%)	8 (73%)
Immunosuppression
Prednisone		27 (100%)	19 (100%)	15 (100%)	11 (100%)
CNI		25 (93%)	17 (89%)	12 (80%)	8 (73%)
Mycophenolate		27 (100%)	16 (84%)	13 (87%)	9 (82%)
Azathioprine		0 (0%)	1 (5%)	2 (13%)	2 (18%)
mTOR inhibitor		2 (7%)	2 (11%)	3 (20%)	3 (27%)

CNI: calcineurin inhibitors; mTOR: mammalian target of rapamycin; results are expressed as count (% of the available data at that point in time).